Top news
Texas recommends resuming Johnson & Johnson vaccine shots after CDC, FDA give green light
By Karen Brooks
Vaccinations are plateauing. Don't blame it on 'resistance'
By Stefanie Friedhoff
Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021)
By Sharon LaFraniere, Chris Hamby & Sheryl Gay Stolberg
All coverage
Congressional investigation launched into Emergent BioSolutions' federal vaccine contracts
By Rich Mendez
COVID-19 vaccine blood clots: Should you be concerned?
By Sean Jackson
FDA report finds multiple failings at plant that ruined 15 million Johnson & Johnson vaccine doses
By Christopher Rowland
L.A. County prepping to resume administering Johnson & Johnson vaccine
By Luke Money & Colleen Shalby
U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately
By Julie Steenhuysen & Manas Mishra
FDA, CDC lift pause on J&J Covid vaccinations
By Erika Edwards & Sara G. Miller
Johnson & Johnson Vaccine: U.S. Lifts Pause : Coronavirus Updates
By Laurel Wamsley
Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume
By Karen Weintraub & Elizabeth Weise
CDC panel voted to resume J&J COVID-19 shots paused for clot concerns
By Tina Hesman Saey
FDA ends Johnson & Johnson vaccine pause - POLITICO
By Sarah Owermohle, David Lim & Erin Banco
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.'s request ...
By Sheryl Gay Stolberg
Johnson & Johnson Vaccine Will Be Available Again Soon
By Denise Grady, Julie Bosman & Noah Mercer Weiland
The public's concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds
By Scott Clement & Amy Goldstein